Counteracting Alzheimer’s disease via normalizing neurovascular unit with a self-regulated multi-functional nano-modulator

Alzheimer’s disease

Targeted delivery

Pathological blood–brain barrier

Neurovascular unit

Receptor for Advanced Glycation End Products

gene delivery

Anti-inflammation

Synergetic therapy

© 2024 Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.

留言 (0)

沒有登入
gif